Generation of induced pluripotent stem cell line-NTUHi001-A from a premature ovarian failure patient with Turner's syndrome mosaicism

Stem Cell Res. 2019 May:37:101422. doi: 10.1016/j.scr.2019.101422. Epub 2019 Apr 2.

Abstract

Turner's syndrome (TS) is one of the main causes of premature ovarian failure (POF). However, the mechanisms underlying POF are difficult to study due to the lack of suitable disease models. Herein, we have generated a human induced pluripotent stem cell (hiPSC) line derived from the peripheral blood mononuclear cells of a female patient with Turner's syndrome mosaicism via integration-free Sendai-virus system. The hiPSCs were confirmed with a 45, X karyotype and the acquisition of pluripotency. It's likely that hiPSCs can serve as a feasible cellular model for further pathophysiological studies of POF cases, especially for those originating in TS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Differentiation*
  • Cells, Cultured
  • Cellular Reprogramming*
  • Female
  • Humans
  • Induced Pluripotent Stem Cells / metabolism
  • Induced Pluripotent Stem Cells / pathology*
  • Leukocytes, Mononuclear / metabolism
  • Leukocytes, Mononuclear / pathology*
  • Mosaicism
  • Phenotype
  • Primary Ovarian Insufficiency / complications
  • Primary Ovarian Insufficiency / genetics
  • Primary Ovarian Insufficiency / pathology*
  • Turner Syndrome / complications
  • Turner Syndrome / genetics
  • Turner Syndrome / pathology*